You are viewing: UK Gastrointestinal Products Market analysis

The UK Gastrointestinal Products Market was valued at $386.4 Million in 2024 and projected to reach to $550.3 Million by 2029, representing a compound annual growth rate of 7.3%. The UK gastrointestinal products market is positioned for sustained growth over the forecast period, with a CAGR of 7.3% significantly outpacing the global average of 6.1%.

UK Gastrointestinal Products Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Gastrointestinal Products Market Trends and Insights

  • The UK market is driven by rising prevalence of digestive disorders, aging demographics, and increased healthcare spending on gastrointestinal treatments.
  • The UK's robust pharmaceutical infrastructure and strong regulatory framework support innovation in this sector. During the forecast period from 2024 to 2029, the UK gastrointestinal products market is expected to benefit from growing consumer awareness, improved diagnostic capabilities, and expanding product portfolios from major manufacturers.
  • The UK's National Health Service (NHS) commitment to digestive health management further accelerates market penetration.
  • Key therapeutic areas including acid reflux, inflammatory bowel disease, and functional gastrointestinal disorders continue to drive demand across the UK market..

Key Market Statistics

  • CAGR (2024-2029) 7.3% CAGR
  • Market Size, 2024 ~USD 386.4 Million
  • Forecast, 2029 ~USD 550.3 Million
  • Country UK

UK Gastrointestinal Products Market Overview

Market Valuation :

The UK gastrointestinal products market reached £386.4 million in 2024, with strong growth trajectory expected to reach £550.3 million by 2029, driven by increased healthcare investment and consumer awareness.

Aging Population Impact :

The UK's aging demographic is a key growth driver, with digestive disorders becoming increasingly prevalent among older populations, creating sustained demand for gastrointestinal treatments and management solutions.

Regulatory Excellence :

The UK's robust pharmaceutical infrastructure and stringent regulatory framework through the MHRA ensure high-quality product standards, fostering consumer trust and supporting market expansion in gastrointestinal therapeutics.

Healthcare Spending Growth :

Increased NHS and private healthcare spending on gastrointestinal treatments reflects growing recognition of digestive health importance, supporting innovation and product development across the UK market.

UK Gastrointestinal Products Market Dynamics

  • This outperformance reflects the UK's aging population, rising prevalence of IBS, IBD, and acid reflux disorders, and increased consumer focus on digestive wellness.
  • Healthcare providers and pharmaceutical companies are investing heavily in innovative treatment options and over-the-counter solutions.
  • The market benefits from strong NHS coverage, private healthcare expansion, and growing e-commerce channels for OTC gastrointestinal products.
  • Regulatory support and clinical research initiatives further strengthen market dynamics, positioning the UK as a key growth market within Europe..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The UK gastrointestinal products market is valued at £386.4 million in 2024 and will reach £550.3 million by 2029.
    • The UK market is growing at a 7.3% CAGR, outpacing the global average of 6.1%.
    • Aging population and rising digestive disorder prevalence are primary growth drivers in the UK.
    • The UK's NHS infrastructure and regulatory environment create favorable conditions for market expansion through 2029.

    Gastrointestinal Products Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment IRRITABLE BOWEL SYNDROME (IBS) (Disease)
    Forecast Period 2024-2029
    Growth Rate CAGR of 6.1% from 2024 to 2029
    Largest Segment ENDOSCOPY DEVICES (Device)
    Market Size Base Year (Billions) ~USD 14.65 (2024)
    Revenue Forecast (Billions) ~USD 19.7 (2029)
    Segments Covered Device, Type, Disease, End User

    UK Gastrointestinal Products Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Device

    • Ablation Devices
    • Biopsy Devices
    • Endoscopy Devices
    • Motility Testing Devices
    • Other Gastroenterology/ Gastrointestinal Devices
    • Other Gastroenterology/Gastrointestinal Devices
    • Ph Monitoring Devices
    • Stenting Devices

    By Type

    • 4-Hour Ph Impedance Testing Devices
    • Ambulatory Ph Monitoring Systems
    • Anorectal Manometry Devices
    • Biliary Stents
    • Capsule Endoscopes
    • Colonic Stents
    • Cryoablation Devices
    • Duodenal Stents
    • Esophageal Manometry Devices
    • Esophageal Ph Monitoring Catheters
    • Esophageal Stents
    • Flexible Endoscopes
    • Gastric Balloons
    • Gastrointestinal Tubes
    • Hemorrhoid Treatment Devices
    • Laser Ablation Devices
    • Microwave Ablation Devices
    • Needle Biopsy Devices
    • Other Ablation Devices
    • Other Biopsy Devices
    • Other Endoscopy Devices
    • Other Motility Testing Devices
    • Pancreatic Stents
    • Radiofrequency Ablation Devices
    • Rigid Endoscopes
    • Wireless Ph Monitoring Capsules

    By Disease

    • Gastroesophageal Reflux Disease (Gerd)
    • Gastrointestinal Cancers
    • Inflammatory Bowel Disease (Ibd)
    • Irritable Bowel Syndrome (Ibs)
    • Other Diseases

    By End User

    • Ambulatory Surgical Centers & Independent Diagnostic Centers
    • Clinics
    • Hospitals
    • Other End Users

    UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    AMBULATORY SURGICAL CENTERS & INDEPENDENT DIAGNOSTIC CENTERS222.3234.2247.7262.2277.6294.1311.6367.38.2
    CLINICS95.298.3101.9105.8109.8114118.4136.96.1
    HOSPITALS295.4314.4335.9359.3384.4411.5440.54094
    OTHER END USERS85.388.391.895.699.5103.6108125.16.4
    TOTAL698.2735.2777.3822.8871.3923.3978.61038.36

    Target Audience

    • Pharmaceutical Manufacturers : UK-based and international pharma companies need detailed market intelligence to develop product portfolios, identify licensing opportunities, and optimize commercial strategies for the growing British GI products market.
    • Healthcare Providers & NHS Trusts : Hospital networks and NHS procurement teams require market data to evaluate treatment options, negotiate supplier contracts, and allocate budgets effectively for gastrointestinal care services across the UK.
    • Medical Device Companies : Manufacturers of diagnostic and therapeutic GI devices need UK-specific market insights to assess demand, understand regulatory pathways, and identify partnership opportunities with healthcare systems.
    • Investment & Private Equity Firms : Investors evaluating UK healthcare opportunities require comprehensive market analysis to assess growth potential, identify acquisition targets, and make informed funding decisions in the gastrointestinal sector.
    • Market Research & Consulting Firms : Research organizations and consultants need granular UK market data to support client advisory services, competitive benchmarking, and strategic planning for healthcare and pharmaceutical clients.

    Reasons to Buy this Report

    • UK-Specific Market Sizing : Access precise valuation data for the UK market (£386.4M in 2024) with detailed forecasts through 2029, enabling accurate budget allocation and investment decisions tailored to the British gastrointestinal products sector.
    • Competitive Landscape Intelligence : Understand UK-specific competitive dynamics, market share distribution among major pharmaceutical players, and emerging competitors in the gastrointestinal products space to inform strategic positioning.
    • Regulatory & Compliance Insights : Gain detailed knowledge of UK MHRA regulations, NHS reimbursement pathways, and post-Brexit pharmaceutical requirements essential for market entry and product commercialization strategies.
    • Growth Driver Analysis : Identify UK-specific growth catalysts including aging demographics, rising IBS/IBD prevalence, NHS spending trends, and consumer behavior patterns driving the 7.3% CAGR in the British market.
    • Strategic Market Opportunities : Discover untapped segments, distribution channels, and partnership opportunities within the UK gastrointestinal market to maximize revenue potential and market penetration in this high-growth region.

    Frequently asked questions

    What is the current size of the UK gastrointestinal products market?

    The UK gastrointestinal products market was valued at £386.4 million in 2024.

    What is the projected market size for the UK by 2029?

    The UK gastrointestinal products market is forecast to reach £550.3 million by 2029.

    What is the growth rate of the UK gastrointestinal products market?

    The UK market is expected to grow at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2029.

    What factors are driving growth in the UK gastrointestinal products market?

    Key drivers include an aging population, rising prevalence of digestive disorders, increased NHS investment in gastrointestinal health, and growing consumer awareness of digestive wellness.

    How does the UK market compare to global growth trends?

    The UK gastrointestinal products market is growing at 7.3% CAGR, which exceeds the global average CAGR of 6.1%, indicating stronger regional demand.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the gastroenterology products market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Gastrointestinal Products Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the Gastroenterology Products Market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the gastrointestinal products market.; and key opinion leaders.

    Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market. the following is a breakdown of the primary respondents:

    Gastroenterology Products Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the gastrointestinal products market includes the following details. The market sizing of the market was undertaken from the global side.

    Country-Level Analysis

    The size of the gastrointestinal products market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall gastrointestinal products market was obtained from secondary data and validated by primary participants to arrive at the total gastroenterology products market. Primary participants further validated the numbers.

    Geographic Market Assessment (By Region & Country)

    • Approach 1:
      • Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends.
    • Approach 2:
      • Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews).

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Gastroenterology/Gastrointestinal Products Market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Gastrointestinal Products Market Size: Bottom-Up Approach

    Global Gastrointestinal Products Market Size: Bottom-Up Approach

    Global Gastrointestinal Products Market Size: Top-Down Approach

    Global Gastrointestinal Products Market Size: Top-Down Approach

    To know about the assumptions considered for the study, Request for Free Sample Report

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the gastrointestinal products market.

    Market Definition

    Gastroenterology products encompass a variety of medical devices, diagnostic tools, and pharmaceuticals designed to diagnose, treat, and manage diseases and disorders of the gastrointestinal tract. These products include endoscopes, capsule endoscopy systems, ablation devices, stents, and specialized medications aimed at conditions like GERD, IBD, and colorectal cancer. Their purpose is to improve patient outcomes by offering advanced solutions for both diagnostic and therapeutic procedures within the GI tract.

    Key Stakeholders

    • Medical Device Manufacturers
    • Healthcare Institutions (hospitals and outpatient clinics)
    • Distributors and Suppliers
    • Research Institutes
    • Health Insurance Payers
    • Market Research and Consulting Firms

    Report Objectives

    • To define, describe, segment, and forecast the global gastrointestinal Products Market by devices, diseases end users, and region.
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall gastrointestinal products market.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
    • To forecast the size of the gastroenterology products market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile key players in the global gastrointestinal products market and comprehensively analyze their core competencies2 and market shares.
    • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
    • To benchmark players within the gastrointestinal products market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolios of each company

    Geographic Analysis

    • Further breakdown of the Latin American apheresis into specific countries and, the Middle East, and Africa apheresis into specific countries and further breakdown of the European apheresis into specific countries

    Get the Full Gastrointestinal Products Market Report

    Full forecast, segment splits, and company analysis for all Gastrointestinal Products Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status